|
|
|
Volumn 2, Issue 7, 2001, Pages 109-111
|
|
UCLA's coronary artery disease initiative begins at the hospital with medication, lifestyle interventions.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ARTICLE;
CORONARY ARTERY ATHEROSCLEROSIS;
DRUG EFFECT;
HEALTH CARE QUALITY;
HOSPITALIZATION;
HUMAN;
LIFESTYLE;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
UNITED STATES;
UNIVERSITY HOSPITAL;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ASPIRIN;
CHOLESTEROL, LDL;
CORONARY ARTERIOSCLEROSIS;
HOSPITALIZATION;
HOSPITALS, UNIVERSITY;
HUMANS;
LIFE STYLE;
LOS ANGELES;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT COMPLIANCE;
PROGRAM EVALUATION;
|
|
EID: 0035404464
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|